
Sign up to save your podcasts
Or


In this comeback episode of Cacao with Kezia, I unpack what the research says about GLP-1 weight-loss drugs (Ozempic/Wegovy/Mounjaro): why most people regain about two-thirds of the weight after stopping, the key risks (gallbladder, gastroparesis, pancreatitis, bone and nutrient concerns), and the four foundations that make results stick,insulin management, sleep & stress, protein & fibre, and understanding your unique root causes.
Compassionate, practical, evidence-informed - and no judgement.
By Kezia Hall4.2
1919 ratings
In this comeback episode of Cacao with Kezia, I unpack what the research says about GLP-1 weight-loss drugs (Ozempic/Wegovy/Mounjaro): why most people regain about two-thirds of the weight after stopping, the key risks (gallbladder, gastroparesis, pancreatitis, bone and nutrient concerns), and the four foundations that make results stick,insulin management, sleep & stress, protein & fibre, and understanding your unique root causes.
Compassionate, practical, evidence-informed - and no judgement.